The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review
Open accessAbstract
Cancer is a medical condition which has a molecular basis. Proto-oncogenes are the first regulatory factors of this biological process. They act in transmitting signals, resulting as growth factors. Modifications of these genes, called oncogenes, lead to the appearance of cancer cells. The activation process leading to proto-oncogenes are chromosomal translocation, point mutation, and gene amplification. Concerning the clonal theory of oncogenesis, it is believed that a tumor starts from a cell. Furthermore, there is close association between tumor development and inhibition of apoptosis or programmed cell death, providing cell immortality. Angiogenesis and angiogenic factors found to be expressed in tumors and may play a key role in tumor formation and development. Tumor-suppressor genes block the growth of cancer and contribute to the normal development of cells. This article highlights the evidence that neoplasms develop as the after-effect of the increase of acquired and physical genetic variations in proto-oncogenes and tumor-suppressor genes; these form a target group in the cells of neoplasms. Tumor formation and development are characterized by individual processes, working synergistically, and an understanding of each individual process may provide a better basis for further anticancer research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes
Bommer, G. T., Gerin, I., Feng, Y., Kaczorowski, A. J., Kuick, R., Love, R. E., Zhai, Y., Giordano, T. J., Qin, Z. S., Moore, B. B., et al. (2007) · Current Biology · doi:10.1016/j.cub.2007.06.068 · Cited by 1,123
Lohr, J. G., Stojanov, P., Lawrence, M. S., Auclair, D., Chapuy, B., Sougnez, C., Cruz-Gordillo, P., Knoechel, B., Asmann, Y. W., Slager, S. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121343109 · Cited by 974
Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics
Jan, R., & Chaudhry, G.-E.-S. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.024 · Cited by 899
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
Collins, M. A., Bednar, F., Zhang, Y., Brisset, J.-C., Galbán, S., Galbán, C. J., Rakshit, S., Flannagan, K. S., Adsay, N. V., & Pasca di Magliano, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59227 · Cited by 770
Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
Welti, J., Loges, S., Dimmeler, S., & Carmeliet, P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70212 · Cited by 591
Bachelder, R. E., Wendt, M. A., & Mercurio, A. M. (2002) · PubMed · Cited by 424
Viruses associated with human cancer
McLaughlin-Drubin, M. E., & Munger, K. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.12.005 · Cited by 406
The Epidemiology of Human Papillomavirus Infection and Cervical Cancer
Bosch, F. X., & de Sanjosé, S. (2007) · Disease Markers · doi:10.1155/2007/914823 · Cited by 357
K-Ras is essential for the development of the mouse embryo
Koera, K., Nakamura, K., Nakao, K., Miyoshi, J., Toyoshima, K., Hatta, T., Otani, H., Aiba, A., & Katsuki, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201284 · Cited by 355
Endothelial Notch1 Activity Facilitates Metastasis
Wieland, E., Rodriguez-Vita, J., Liebler, S. S., Mogler, C., Moll, I., Herberich, S. E., Espinet, E., Herpel, E., Menuchin, A., Chang-Claude, J., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.007 · Cited by 314
Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice
Soucek, L., Whitfield, J. R., Sodir, N. M., Massó-Vallés, D., Serrano, E., Karnezis, A. N., Swigart, L. B., & Evan, G. I. (2013) · Genes & Development · doi:10.1101/gad.205542.112 · Cited by 301
Ayyanan, A., Civenni, G., Ciarloni, L., Morel, C., Mueller, N., Lefort, K., Mandinova, A., Raffoul, W., Fiche, M., Dotto, G. P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600065103 · Cited by 294
Notch signaling regulates tumor angiogenesis by diverse mechanisms
Dufraine, J., Funahashi, Y., & Kitajewski, J. (2008) · Oncogene · doi:10.1038/onc.2008.227 · Cited by 277
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
Klinakis, A., Szabolcs, M., Politi, K., Kiaris, H., Artavanis-Tsakonas, S., & Efstratiadis, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603371103 · Cited by 207
Interleukin-8 in Breast Cancer Progression
Todorović-Raković, N., & Milovanović, J. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0023 · Cited by 186
Metastatic pancreatic cancer is dependent on oncogenic Kras in mice
Collins, M. A., Brisset, J.-C., Zhang, Y., Bednar, F., Pierre, J., Heist, K. A., Galbán, C. J., Galbán, S., & di Magliano, M. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049707 · Cited by 178
Notch1 loss of heterozygosity causes vascular tumors and lethal hemorrhage in mice
Liu, Z., Turkoz, A., Jackson, E. N., Corbo, J. C., Engelbach, J. A., Garbow, J. R., Piwnica-Worms, D. R., & Kopan, R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43114 · Cited by 119
Nenclares, P., & Harrington, K. J. (2020) · Medicine · doi:10.1016/j.mpmed.2019.11.001 · Cited by 101
Entire mitogen activated protein kinase (MAPK) pathway is present in preimplantation mouse embryos
Wang, Y., Wang, F., Sun, T., Trostinskaia, A., Wygle, D., Puscheck, E. E., & Rappolee, D. A. (2004) · Developmental Dynamics · doi:10.1002/dvdy.20114 · Cited by 78
Rykałą, J., Przybyłowska, K., Majsterek, I., Pasz‐Walczak, G., Sygut, A., Dziki, A. J., & Kruk‐Jeromin, J. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9387-6 · Cited by 71
Biological and clinical significance of her2 overexpression in Breast Cancer
Kurebayashi, J. (2001) · Breast Cancer · doi:10.1007/bf02967477 · Cited by 71
Modeling and Targeting MYC Genes in Childhood Brain Tumors
Hutter, S., Bolin, S., Weishaupt, H., & Swartling, F. J. (2017) · Genes · doi:10.3390/genes8040107 · Cited by 39
The Impact of microRNAs in Breast Cancer Angiogenesis and Progression
Kontomanolis, E. N., Fasoulakis, Z. N., Papamanolis, V., Koliantzaki, S. G., Dimopoulos, G., & Kambas, N. J. (2018) · MicroRNA · doi:10.2174/2211536607666181017122921 · Cited by 21
Self-citationAbel, E. L., & DiGiovanni, J. (2010) · Humana Press eBooks · doi:10.1007/978-1-61737-995-6_2 · Cited by 17
Expression Analysis of MYC Genes from Tamarix hispida in Response to Different Abiotic Stresses
Ji, X., Wang, Y., & Liu, G. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13021300 · Cited by 16
Cancer screening in women living with HIV infection
Aboulafia, D. M. (2017) · Women s Health · doi:10.1177/1745505717731970 · Cited by 16
Chen, J. J. ‐., & Podlevsky, J. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.10042-2 · Cited by 14
Cited by
Lung Cancer—Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature)
Smolarz, B., Łukasiewicz, H., Samulak, D., Piekarska, E., Kołaciński, R., & Romanowicz, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052049 · Cited by 259
Flavonoids: A Myth or a Reality for Cancer Therapy?
Forni, C., Rossi, M., Borromeo, I., Feriotto, G., Platamone, G., Tabolacci, C., Mischiati, C., & Beninati, S. (2021) · Molecules · doi:10.3390/molecules26123583 · Cited by 79
Postwala, H., Shah, Y., Parekh, P. S., & Chorawala, M. R. (2023) · Medical Oncology · doi:10.1007/s12032-023-02201-8 · Cited by 26
Metadata
- Authors
- KONTOMANOLIS, E. N., KOUTRAS, A., SYLLAIOS, A., SCHIZAS, D., MASTORAKI, A., GARMPIS, N., DIAKOSAVVAS, M., ANGELOU, K., TSATSARIS, G., PAGKALOS, A., NTOUNIS, T., & FASOULAKIS, Z.
- Venue
- Anticancer Research
- Published
- 2020-10-27
- Volume
- 40
- Issue
- 11
- Pages
- 6009-6015
- ISSN
- 0250-7005 (ISSN-L)
- 1791-7530
- OpenAlex
- W3097409164
- Cited by
- 389
- References
- 30
- FWCI
- 14.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.